Trial intelligence / Profile preview

Preemptive Tapentadol for Post-operative Pain in Total Knee Arthroplasty

NCT03351517Completed

Sponsor
AIIMS New Delhi
Start
Nov 2017
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tapentadol in postoperative pain, sponsored by AIIMS New Delhi. Primary endpoint: Visual Analogue Scale at 24 hours. Started Nov 2017; status: completed.

02

Drugs

tapentadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03351517.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03351517.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call